Table 4.

Melanoma metastases immune infiltration in the two clinical benefit groups

	Durable benefit		No benefit		Total
	Count	%	Count	%	Count	%
Pattern of T cell infiltration
A	0	0	1	9.1	1	5.5
B	6	85.7	6	54.5	12	66.6
C	1	14.3	2	18.2	3	16.6
Heterogenous	0	0	2	18.2	2	11.1
Total	7	100	11	100	18	100
CD20+ cells
No	2	28.6	8	72.7	10	55.5
Yes	5	71.4	3	27.3	8	44.4
Total	7	100	11	100	18	100
CD8_PD-L1 pattern
A	2	28.6	6	50	8	42.1
B	5	71.4	6	50	11	57.9
Total	7	100	12	100	19	100